Exosome RNA Exosome RNA Research & Industry News
COVID-19, caused by the SARS-CoV-2 virus, affects various tissues in the body and can lead to significant changes at the cellular level. One important aspect of this impact involves extracellular vesicles (EVs)—tiny particles released from cells that play a crucial role in cell communication. During a COVID-19 infection, the production and function of these EVs can change, reflecting the altered state of the infected cells.
EVs can offer valuable insights into the condition of a patient, as they mirror the state of their cell of origin. However, detecting these small EVs can be challenging due to their size and the specific cellular compartments they come from. Flow cytometry has emerged as a powerful tool for analyzing EVs, particularly in the context of COVID-19.
Researchers at the University of Rome Tor Vergata highlights how plasmatic EVs (those found in blood) are involved in COVID-19 and Long COVID (LC), a condition where symptoms persist long after the initial infection. EVs can have both pro- and antiviral effects, making them a double-edged sword in the context of the disease.
Flow cytometry is especially useful for characterizing these circulating EVs due to its ability to analyze multiple parameters simultaneously. This technique helps in understanding how EVs contribute to the infection and potentially to chronic issues that can arise after the infection has cleared.
Examining EVs through methods like flow cytometry can provide valuable information about the progression and lingering effects of COVID-19, offering new insights into the management and treatment of both acute and long-term symptoms.
